Norovirus and sapovirus antigens
    1.
    发明授权
    Norovirus and sapovirus antigens 有权
    诺如病毒和滑鼠病毒抗原

    公开(公告)号:US08124104B2

    公开(公告)日:2012-02-28

    申请号:US12383420

    申请日:2009-03-24

    摘要: Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described. In particular, the invention relates to polynucleotides encoding one or more capsid proteins or other immunogenic viral polypeptides from one or more strains of Norovirus and/or Sapovirus, coexpression of such immunogenic viral polypeptides with adjuvants, and methods of using the polynucleotides in applications including immunization and production of immunogenic viral polypeptides and viral-like particles (VLPs). Methods for producing Norovirus- or Sapovirus-derived multiple epitope fusion antigens or polyproteins and immunogenic compositions comprising one or more immunogenic polypeptides, polynucleotides, VLPs, and/or adjuvants are also described. The immunogenic compositions of the invention may also contain antigens other than Norovirus or Sapovirus antigens, including antigens that can be used in immunization against pathogens that cause diarrheal diseases, such as antigens derived from rotavirus.

    摘要翻译: 描述了引起针对诺如病毒和曙红病毒抗原的免疫应答的免疫原性组合物。 特别地,本发明涉及编码来自一种或多种诺如病毒和/或札幌病毒株的一种或多种衣壳蛋白或其它免疫原性病毒多肽的多核苷酸,这种免疫原性病毒多肽与佐剂的共表达,以及在包括免疫的应用中使用多核苷酸的方法 以及产生免疫原性病毒多肽和病毒样颗粒(VLP)。 还描述了用于生产包含一种或多种免疫原性多肽,多核苷酸,VLP和/或佐剂的诺如病毒或札幌病毒衍生的多表位融合抗原或多蛋白的免疫原性组合物的方法。 本发明的免疫原性组合物还可以含有除诺如病毒或札幌病毒抗原以外的抗原,包括可用于免疫引起腹泻疾病的病原体的抗原,例如来源于轮状病毒的抗原。

    PHARMACEUTICAL COMPOSITIONS, COMPRISING A COMBINATION OF SELECT CARRIERS, VITAMINS, TANNINS AND FLAVONOIDS AS ANTIGEN-SPECIFIC IMMUNO-MODULATORS
    2.
    发明申请
    PHARMACEUTICAL COMPOSITIONS, COMPRISING A COMBINATION OF SELECT CARRIERS, VITAMINS, TANNINS AND FLAVONOIDS AS ANTIGEN-SPECIFIC IMMUNO-MODULATORS 审中-公开
    药物组合物,包含选择载体,维生素,鞣剂和氟虫酯作为抗原特异性免疫调节剂的组合

    公开(公告)号:US20130028961A1

    公开(公告)日:2013-01-31

    申请号:US13531433

    申请日:2012-06-22

    摘要: The present invention provides adjuvant compositions that are capable of modulating the immune response in a subject, including enhancing or suppressing the immune response. These adjuvant compositions may also be used to enhance or suppress the immunogenicity of antigens by enhancing or suppressing antigen-presentation activity, enhancing or suppressing innate immune responses through activation or suppression of, e.g., natural killer cells, and/or direct activation of subsets of B and/or T cells. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions. In certain embodiments, the compositions comprise combinations of the following: a pharmaceutically acceptable carrier, a flavonoid, a tannin and a vitamin. The compositions may further comprise an antigen.

    摘要翻译: 本发明提供能够调节受试者的免疫应答的佐剂组合物,包括增强或抑制免疫应答。 这些佐剂组合物还可用于通过增强或抑制抗原呈递活性来增强或抑制抗原的免疫原性,通过激活或抑制例如天然杀伤细胞增强或抑制先天免疫应答,和/或直接激活 B和/或T细胞。 还提供了制备佐剂组合物的方法以及使用佐剂组合物的方法。 在某些实施方案中,组合物包含以下组合:药学上可接受的载体,类黄酮,单宁和维生素。 组合物还可以包含抗原。

    Norovirus and Sapovirus antigens
    4.
    发明申请
    Norovirus and Sapovirus antigens 有权
    诺如病毒和痘病毒抗原

    公开(公告)号:US20110014219A1

    公开(公告)日:2011-01-20

    申请号:US12383425

    申请日:2009-03-24

    摘要: Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described. In particular, the invention relates to polynucleotides encoding one or more capsid proteins or other immunogenic viral polypeptides from one or more strains of Norovirus and/or Sapovirus, coexpression of such immunogenic viral polypeptides with adjuvants, and methods of using the polynucleotides in applications including immunization and production of immunogenic viral polypeptides and viral-like particles (VLPs). Methods for producing Norovirus- or Sapovirus-derived multiple epitope fusion antigens or polyproteins and immunogenic compositions comprising one or more immunogenic polypeptides, polynucleotides, VLPs, and/or adjuvants are also described. The immunogenic compositions of the invention may also contain antigens other than Norovirus or Sapovirus antigens, including antigens that can be used in immunization against pathogens that cause diarrheal diseases, such as antigens derived from rotavirus.

    摘要翻译: 描述了引起针对诺如病毒和曙红病毒抗原的免疫应答的免疫原性组合物。 特别地,本发明涉及编码来自一种或多种诺如病毒和/或札幌病毒株的一种或多种衣壳蛋白或其它免疫原性病毒多肽的多核苷酸,这种免疫原性病毒多肽与佐剂的共表达,以及在包括免疫的应用中使用多核苷酸的方法 以及产生免疫原性病毒多肽和病毒样颗粒(VLP)。 还描述了用于生产包含一种或多种免疫原性多肽,多核苷酸,VLP和/或佐剂的诺如病毒或札幌病毒衍生的多表位融合抗原或多蛋白的免疫原性组合物的方法。 本发明的免疫原性组合物还可以含有除诺如病毒或札幌病毒抗原以外的抗原,包括可用于免疫引起腹泻疾病的病原体的抗原,例如来源于轮状病毒的抗原。

    NOROVIRUS AND SAPOVIRUS ANTIGENS
    6.
    发明申请
    NOROVIRUS AND SAPOVIRUS ANTIGENS 审中-公开
    NOROVIRUS和SAPOVIRUS抗原

    公开(公告)号:US20110104192A1

    公开(公告)日:2011-05-05

    申请号:US12965344

    申请日:2010-12-10

    摘要: Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described. In particular, the invention relates to polynucleotides encoding one or more capsid proteins or other immunogenic viral polypeptides from one or more strains of Norovirus and/or Sapovirus, coexpression of such immunogenic viral polypeptides with adjuvants, and methods of using the polynucleotides in applications including immunization and production of immunogenic viral polypeptides and viral-like particles (VLPs). Methods for producing Norovirus- or Sapovirus-derived multiple epitope fusion antigens or polyproteins and immunogenic compositions comprising one or more immunogenic polypeptides, polynucleotides, VLPs, and/or adjuvants are also described. The immunogenic compositions of the invention may also contain antigens other than Norovirus or Sapovirus antigens, including antigens that can be used in immunization against pathogens that cause diarrheal diseases, such as antigens derived from rotavirus.

    摘要翻译: 描述了引起针对诺如病毒和曙红病毒抗原的免疫应答的免疫原性组合物。 特别地,本发明涉及编码来自一种或多种诺如病毒和/或札幌病毒株的一种或多种衣壳蛋白或其它免疫原性病毒多肽的多核苷酸,这种免疫原性病毒多肽与佐剂的共表达,以及在包括免疫的应用中使用多核苷酸的方法 以及产生免疫原性病毒多肽和病毒样颗粒(VLP)。 还描述了用于生产包含一种或多种免疫原性多肽,多核苷酸,VLP和/或佐剂的诺如病毒或札幌病毒衍生的多表位融合抗原或多蛋白的免疫原性组合物的方法。 本发明的免疫原性组合物还可以含有除诺如病毒或札幌病毒抗原以外的抗原,包括可用于免疫引起腹泻疾病的病原体的抗原,例如来源于轮状病毒的抗原。

    Norovirus and sapovirus antigens
    8.
    发明申请
    Norovirus and sapovirus antigens 有权
    诺如病毒和滑鼠病毒抗原

    公开(公告)号:US20070207526A1

    公开(公告)日:2007-09-06

    申请号:US11603913

    申请日:2006-11-22

    IPC分类号: C12Q1/68 C12P19/34

    摘要: Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described. In particular, the invention relates to polynucleotides encoding one or more capsid proteins or other immunogenic viral polypeptides from one or more strains of Norovirus and/or Sapovirus, coexpression of such immunogenic viral polypeptides with adjuvants, and methods of using the polynucleotides in applications including immunization and production of immunogenic viral polypeptides and viral-like particles (VLPs). Methods for producing Norovirus- or Sapovirus-derived multiple epitope fusion antigens or polyproteins and immunogenic compositions comprising one or more immunogenic polypeptides, polynucleotides, VLPs, and/or adjuvants are also described. The immunogenic compositions of the invention may also contain antigens other than Norovirus or Sapovirus antigens, including antigens that can be used in immunization against pathogens that cause diarrheal diseases, such as antigens derived from rotavirus.

    摘要翻译: 描述了引起针对诺如病毒和曙红病毒抗原的免疫应答的免疫原性组合物。 特别地,本发明涉及编码来自一种或多种诺如病毒和/或札幌病毒株的一种或多种衣壳蛋白或其它免疫原性病毒多肽的多核苷酸,这种免疫原性病毒多肽与佐剂的共表达,以及在包括免疫的应用中使用多核苷酸的方法 以及产生免疫原性病毒多肽和病毒样颗粒(VLP)。 还描述了用于生产包含一种或多种免疫原性多肽,多核苷酸,VLP和/或佐剂的诺如病毒或札幌病毒衍生的多表位融合抗原或多蛋白的免疫原性组合物的方法。 本发明的免疫原性组合物还可以含有除诺如病毒或札幌病毒抗原以外的抗原,包括可用于免疫引起腹泻疾病的病原体的抗原,例如来源于轮状病毒的抗原。

    Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators

    公开(公告)号:US10561720B2

    公开(公告)日:2020-02-18

    申请号:US13531433

    申请日:2012-06-22

    IPC分类号: A61K39/12 A61K39/39 A61K39/00

    摘要: The present invention provides adjuvant compositions that are capable of modulating the immune response in a subject, including enhancing or suppressing the immune response. These adjuvant compositions may also be used to enhance or suppress the immunogenicity of antigens by enhancing or suppressing antigen-presentation activity, enhancing or suppressing innate immune responses through activation or suppression of, e.g., natural killer cells, and/or direct activation of subsets of B and/or T cells. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions. In certain embodiments, the compositions comprise combinations of the following: a pharmaceutically acceptable carrier, a flavonoid, a tannin and a vitamin. The compositions may further comprise an antigen.